Science Market Update

Mt. Sinai Receives $15M to Develop New Alzheimer's Research Center

Posted by Laura Braden on Fri, Jan 30, 2015

The Mount Sinai Health System in New York, composed of a medical school and seven hospitals throughout New York City, is a leading institution in life science research. Scientists here frequently produce leading research results and publish beneficial papers to the life sciences. Within the medical school and the hospitals, there are dozens of research centers and institutes that perform this world-class research.

Get more market visibility at Mount Sinai School of MedicineExisting research centers include: 

  • Alcoholic Liver Disease Research Center
  • Alzheimer's Disease Research Center
  • Brain Injury Research Center of Mount Sinai
  • Cardiovascular Research Center
  • Center for Molecular Cardiology
  • Fibrosis Research Center
  • Niemann Pick Disease Center
  • Seaver Autism Center for Research and Treatment
  • Stroke Center

With the help of a recent $15 million gift, the Mount Sinai Health System will be creating a new research center - The Ronald M. Loeb Center for Alzheimer’s Disease. (Image courtesy of WIkimedia Commons)

This donation comes from Daniel Loeb, CEO and Founder of Third Point LLC, who plans to establish the center in memory of his father, who suffered from Alzheimer's disease. 

Daniel Loeb donated to Mount Sinai because he is impressed by the work that Mount Sinai has already made in advancing Alzheimer's research. “Mount Sinai has been at the forefront of Alzheimer’s research, starting with Dr. Ken Davis several decades ago. It is my hope that this Center, with its multi-departmental approach and expertise in stem cell research and genomics, will bring together the best in the field to find the breakthrough we so urgently need,” explained Loeb. 


The new center at Mount Sinai in New York will study Alzheimer's disease.

(Image courtesy of Wikimedia Commons)



This new Ronald M. Loeb Center for Alzheimer's Disease will be the second center at Mount Sinai dedicated to the study of Alzheimer's, and these two centers will work closely together on certain projects. The new center will also be involved in research programs that span the Mount Sinai Health System, including working with the Friedman Brain Institute and Icahn Institute for Genomics and Multiscale Biology, amongst others. 

Mount Sinai School of Medicine has been a leader in researching Alzheimer's disease for many years. Developments in Alzheimer's research and clinical care that have occurred at Mount Sinai include:

  • Research at Mount Sinai led to the development of Cognex, the first FDA approved drug to treat Alzheimer's.
  • Dr. Ken Davis of Mount Sinai developed the Alzheimer's Disease Assessment Scale which is widely used around the world.
  • The NIH has been continuously been giving funding to Mount Sinai for Alzheimer's research since 1986.
  • The Alzheimer's disease brain bank is the largest in the world with more that 12,000 samples. 


Researchers at Mount Sinai in New York City enjoy attending vendor shows to find new lab supplies.

(Image courtesy of Wikimedia Commons


Along with being a leading institution in Alzheimer's research, researchers at Mount Sinai School of Medicine make important contributions to all fields of the life sciences, and receives substantial amounts of funding for these projects. 

Current funded research projects at Mount Sinai School of Medicine include:

  • $10 million has been committed to the Jaffe Food Allergy Institute at The Mount Sinai Medical Center which will create the David H. and Julia Koch Research Program.
  • The Brain Injury Research Center at Mount Sinai received grants totaling $6.65 million over a five year period to research traumatic brain injury.
  • Mount Sinai researchers received a 5-year $6 million NIH grant to lead a consortium studying autism and intellectual disability.
  • Mount Sinai Medical Center received a four-year $3.4 million grant from the National Human Genome Research Institute to conduct a study in which a patient’s genomic risk for disease is revealed in a lab and then entered into an electronic medical record for use in determining treatment in the clinical care setting.

Due to its research achievements and high amounts of funding, Mount Sinai School of Medicine is an excellent place for lab supply companies to market lab products to life science researchers. Biotechnology Calendar, Inc. holds an annual BioResearch Product Faire™ Event at Mount Sinai that gives New York area researchers the opportunity to find new lab supplies. Lab supply companies at this annual event have the chance to meet with over 200 researchers, PI's, lab managers, post docs, and other lab staff to demonstrate and discuss their supplies with the people in charge of purchasing and using this equipment. 

To learn more about participating in the upcoming 10th annual BioResearch Product Faire™ Event at Mount Sinai School of Medicine on March 25, 2015, as either an exhibitor or researcher, visit the appropriate link below: 

Exhibit: Icahn       Researchers: Attend Mount Sinai Event


During the week of this Mount Sinai event, there will also be two other BioResearch Product Faire™ Events happening in New York. Click on the links below to learn about participating in an event at Columbia University or Rockefeller University. 


Columbia University       5th semiannual BioResearch Product Faire™ Event     March 24, 2015

Rockefeller University    18th semiannual BioResearch Product Faire™ Event    March 26, 2015


Tags: Mount Sinai School of Medicine, Northeast, New York, 2015, Alzheimer’s, Neuroscience, MSSM, BioResearch Product Faire Event, NY, New research center

Subscribe to Company News